CliffBio
small molecule

TENOFOVIR ALAFENAMIDE FUMARATE

TENOFOVIR ALAFENAMIDE FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameTENOFOVIR ALAFENAMIDE FUMARATE
Active ingredientTENOFOVIR ALAFENAMIDE FUMARATE
StrengthEQ 25MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2024
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.